Propanc Biopharma, Inc. (PPCB)
0.3135
-0.04
(-10.76%)
USD |
NASDAQ |
Jan 16, 16:00
0.3162
0.00 (0.00%)
After-Hours: 20:00
Propanc Biopharma EPS Diluted (Quarterly): -0.3923 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lumos Diagnostics Holdings Ltd. | -- |
| Incannex Healthcare, Inc. | -0.0206 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.838M |
| Total Expenses (Quarterly) | 4.838M |
| Enterprise Value | 4.282M |
| Earnings Yield | -14.75K% |
| Normalized Earnings Yield | -14584.88 |